Taliglucerase alfa in Gaucher disease: Description of a Brazilian experience

Título:

Taliglucerase alfa in Gaucher disease: Description of a Brazilian experience

Autor:

Tatiana Guimaraes de Noronha

Ano:

2017

DOI:

10.1016/j.bcmd.2017.01.005

Revista:

BLOOD CELLS MOLECULES AND DISEASES

ISSN:

10799796

Home:

[doi:10.1016/j.bcmd.2017.01.005]

Idioma:

Inglês

Buscar essa publicação no Google Acadêmico

Publicações com a mesma autoria

A prospective, multicentre, cohort study to assess the incidence of dengue illness in households from selected communities in Brazil (2014-2018)

Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine

Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study

Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study

Controvérsias sobre a ampliação das áreas com vacinação de rotina contra a febre amarela no Brasil

Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies

Booster dose after 10 years is recommended following 17DD-YF primary vaccination

Immunogenicity, reactogenicity and consistencyof production of a combined Brazilian vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b

Incidência de episódios hipotônicos-hiporresponsivos associados à vacina combinada DTP/Hib usada no Programa Nacional de Imunizações